FR2227874A1 - - Google Patents

Info

Publication number
FR2227874A1
FR2227874A1 FR7415430A FR7415430A FR2227874A1 FR 2227874 A1 FR2227874 A1 FR 2227874A1 FR 7415430 A FR7415430 A FR 7415430A FR 7415430 A FR7415430 A FR 7415430A FR 2227874 A1 FR2227874 A1 FR 2227874A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7415430A
Other versions
FR2227874B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2227874A1 publication Critical patent/FR2227874A1/fr
Application granted granted Critical
Publication of FR2227874B1 publication Critical patent/FR2227874B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/008Preparations for oily hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7415430A 1973-05-03 1974-05-03 Expired FR2227874B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2322232A DE2322232A1 (de) 1973-05-03 1973-05-03 Neue acylaminosaeureamide

Publications (2)

Publication Number Publication Date
FR2227874A1 true FR2227874A1 (fr) 1974-11-29
FR2227874B1 FR2227874B1 (fr) 1977-11-10

Family

ID=5879881

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7415430A Expired FR2227874B1 (fr) 1973-05-03 1974-05-03

Country Status (12)

Country Link
US (1) US3948943A (fr)
JP (1) JPS5029754A (fr)
AT (1) AT330761B (fr)
BE (1) BE814476A (fr)
CH (1) CH604704A5 (fr)
DE (1) DE2322232A1 (fr)
ES (1) ES425215A1 (fr)
FR (1) FR2227874B1 (fr)
GB (1) GB1445503A (fr)
IL (1) IL44742A (fr)
NL (1) NL7405324A (fr)
NO (1) NO741580L (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017513A (en) * 1975-03-17 1977-04-12 Abbott Laboratories Method for making aminoacid amides
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
US4374125A (en) * 1978-06-05 1983-02-15 Helene Curtis Industries, Inc. Hair moisturizing compositions
US4220166A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of restoring normal moisture level to hair with severe moisture deficiency
US4220167A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of restoring normal moisture level to hair with slight to moderate moisture deficiency
US4220168A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of moisturizing and maintaining normal moisture level in hair having a normal moisture content
US4452989A (en) * 1982-06-01 1984-06-05 Charles Of The Ritz Group Ltd. Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
US4590069A (en) * 1982-06-01 1986-05-20 Charles Of The Ritz Group Ltd. Novel substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
US4762704A (en) * 1983-06-22 1988-08-09 Bristol-Myers Company Antiperspirant compositions, containing certain antihistamines and certain antihistamine enhancers
DK255889D0 (da) * 1989-05-25 1989-05-25 Novo Nordisk As Fremgangsmaade til fremstilling af organiske forbindelser
DE4407193A1 (de) * 1994-03-04 1995-09-07 Asta Medica Ag Langkettige Alkylamide von Aminosäuren und Peptiden mit antiproliferativen und entzündungshemmenden Eigenschaften
DE19828643A1 (de) * 1998-06-26 1999-12-30 Wella Ag Einphasiges, schaumförmiges Haarbehandlungsmittel zur Erzielung eines Pomadeneffektes
US6667045B2 (en) 1999-10-01 2003-12-23 Joseph Scott Dahle Topical applications for skin treatment
FR2826263B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
FR2826265B1 (fr) * 2001-06-26 2005-02-18 Oreal Composition cosmetique ou dermatologique comprenant une association entre un inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent antifongique et/ou antibacterien
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
EA009646B1 (ru) * 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen
US20180250292A1 (en) * 2015-09-04 2018-09-06 Indiana University Research And Technology Corporation Antibiotic gel formulation and methods of preparing the antibiotic gel formulation

Also Published As

Publication number Publication date
US3948943A (en) 1976-04-06
GB1445503A (en) 1976-08-11
ES425215A1 (es) 1976-05-16
NO741580L (no) 1974-11-05
FR2227874B1 (fr) 1977-11-10
DE2322232A1 (de) 1974-11-14
CH604704A5 (fr) 1978-09-15
BE814476A (fr) 1974-11-04
ATA334474A (de) 1975-10-15
AT330761B (de) 1976-07-26
NL7405324A (fr) 1974-11-05
AU6849774A (en) 1975-11-06
IL44742A0 (en) 1974-07-31
IL44742A (en) 1977-07-31
JPS5029754A (fr) 1975-03-25

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
FR2227874B1 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AR200885A1 (fr)
AR196382A1 (fr)
AR200256A1 (fr)
AU477824B2 (fr)
AR210729A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse